Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsJubilant biosys

    Jubilant Biosys

    Jump to

    • Jubilant Life signs $180 mn outlicensing deal with Checkpoint

      The company's subsidiary Jubilant Biosys and Checkpoint Therapeutics Inc have signed an exclusive, worldwide license deal, under which Checkpoint will assume all its further pre-clinical, clinical development and commercialisation responsibilities, JLS said in a BSE filing.

    • Jubilant Biosys gets milestone payment from AstraZeneca

      Jubilant Biosys, a unit of Jubilant Life Sciences, on Thursday said it has received an undisclosed amount as a milestone payment from AstraZeneca for its research on pain management in the neuroscience therapeutic area.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347